Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.28 USD -1.19% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Aurinia Pharmaceuticals Inc

Current Assets 440.5m
Cash & Short-Term Investments 348.2m
Receivables 36.5m
Other Current Assets 55.7m
Non-Current Assets 108.9m
PP&E 103.5m
Intangibles 4.5m
Other Non-Current Assets 868k
Current Liabilities 78.6m
Accounts Payable 8.9m
Accrued Liabilities 47.9m
Other Current Liabilities 21.8m
Non-Current Liabilities 82.8m
Long-Term Debt 66m
Other Non-Current Liabilities 16.8m

Balance Sheet
Aurinia Pharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
23
6
40
166
118
306
272
232
94
49
Cash
0
6
0
0
0
0
0
0
0
0
Cash Equivalents
23
0
40
166
118
306
272
232
94
49
Short-Term Investments
10
10
0
8
8
0
126
234
295
302
Total Receivables
0
0
0
0
0
0
1
15
14
24
Accounts Receivables
0
0
0
0
0
0
1
15
14
24
Other Receivables
0
0
0
0
0
0
1
0
0
0
Inventory
0
0
0
0
0
0
14
19
25
40
Other Current Assets
1
1
2
2
7
9
6
13
15
11
Total Current Assets
34
17
41
175
133
315
419
513
443
425
PP&E Net
0
0
0
0
0
0
10
10
9
117
PP&E Gross
0
0
0
0
0
0
10
10
9
117
Accumulated Depreciation
0
3
0
0
0
0
0
1
2
2
Intangible Assets
19
17
16
14
13
9
9
8
6
5
Long-Term Investments
0
0
0
0
0
0
24
0
0
0
Other Long-Term Assets
0
0
0
0
0
0
0
12
13
2
Total Assets
52
N/A
34
-36%
57
+70%
190
+233%
146
-23%
324
+122%
464
+43%
543
+17%
471
-13%
548
+16%
Liabilities
Accounts Payable
3
2
3
4
3
4
3
4
12
4
Accrued Liabilities
0
1
3
4
4
7
23
32
29
50
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
15
Other Current Liabilities
0
0
2
0
0
0
6
5
6
8
Total Current Liabilities
3
4
8
8
7
11
32
41
46
77
Long-Term Debt
0
0
0
0
0
0
0
0
0
75
Other Liabilities
16
10
13
16
26
14
24
24
19
17
Total Liabilities
19
N/A
14
-26%
21
+54%
24
+15%
33
+38%
26
-23%
56
+118%
64
+15%
65
+2%
170
+160%
Equity
Common Stock
260
262
300
499
505
747
944
1 177
1 185
1 200
Retained Earnings
237
257
280
351
416
473
575
756
864
942
Additional Paid In Capital
12
16
17
18
25
25
39
59
86
121
Other Equity
1
1
1
1
1
1
1
1
1
1
Total Equity
34
N/A
20
-41%
36
+80%
166
+360%
113
-32%
299
+165%
408
+37%
479
+17%
405
-15%
378
-7%
Total Liabilities & Equity
52
N/A
34
-36%
57
+70%
190
+233%
146
-23%
324
+122%
464
+43%
543
+17%
471
-13%
548
+16%
Shares Outstanding
Common Shares Outstanding
31
32
53
84
86
112
127
142
142
144

See Also

Discover More